In Medline im Jahr 2006 gelistete Publikationen (n=83) von wissenschaftlichen Mitarbeiterinnen und Mitarbeitern der Frauenklinik (Klinik und Forschung) der TU München (Stand: 06.02.2007)

  1. Al-Batran SE, Meerpohl HG, von Minckwitz G, Atmaca A, Kleeberg U, Harbeck N, Lerbs W, Hecker D, Sehouli J, Knuth A, Jager E. Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer. Oncology. 2006;70(2):141-6. Epub 2006 Apr 26. IF=1,985
  2. Beaufort N, Debela M, Creutzburg S, Kellermann J, Bode W, Schmitt M, Pidard D, Magdolen V. Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR). Biol Chem. 2006 Feb;387(2):217-22. IF=2,577
  3. Becker-Pauly C, Howel M, Walker T, Vlad A, Aufenvenne K, Oji V, Lottaz D, Sterchi EE, Debela M, Magdolen V, Traupe H, Stocker W. The alpha and beta Subunits of the Metalloprotease Meprin Are Expressed in Separate Layers of Human Epidermis, Revealing Different Functions in Keratinocyte Proliferation and Differentiation. J Invest Dermatol. 2006 Dec 28; [Epub ahead of print] IF=4,406
  4. Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL, Schnell O, Niemeyer M, Kessler H, Wester HJ, Weber WA, Schwaiger M. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res. 2006 Jul 1;12(13):3942-9. IF=5,715
  5. Beer AJ, Haubner R, Wolf I, Goebel M, Luderschmidt S, Niemeyer M, Grosu AL, Martinez MJ, Wester HJ, Weber WA, Schwaiger M. PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression. J Nucl Med. 2006 May;47(5):763-9. IF=4,684
  6. Binder V, Albert MH, Kabus M, Bertone M, Meindl A, Belohradsky BH. The genotype of the original Wiskott phenotype. N Engl J Med. 2006 Oct 26;355(17):1790-3. IF=44,016
  7. Borgono CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin Cancer Res. 2006 Mar 1;12(5):1487-93. IF=5,715
  8. Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem. 2006 May 19;281(20):14026-40. IF=5,854
  9. Burwinkel B, Shanmugam KS, Hemminki K, Meindl A, Schmutzler RK, Sutter C, Wappenschmidt B, Kiechle M, Bartram CR, Frank B. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer. 2006 Nov 17;6:268. IF=1,992
  10. Debela M, Magdolen V, Grimminger V, Sommerhoff C, Messerschmidt A, Huber R, Friedrich R, Bode W, Goettig P. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. J Mol Biol. 2006 Oct 6;362(5):1094-107. IF=5,229
  11. Debela M, Magdolen V, Schechter N, Valachova M, Lottspeich F, Craik CS, Choe Y, Bode W, Goettig P. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J Biol Chem. 2006 Sep 1;281(35):25678-88. IF=5,854
  12. Diehl P, Steinhauser E, Gollwitzer H, Heister C, Schauwecker J, Milz S, Mittelmeier W, Schmitt M. Biomechanical and immunohistochemical analysis of high hydrostatic pressure-treated Achilles tendons. J Orthop Sci. 2006 Jul;11(4):380-5. IF=0,0
  13. Dorn J, Harbeck N, Kates R, Magdolen V, Grass L, Soosaipillai A, Schmalfeldt B, Diamandis EP, Schmitt M. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma. Biol Chem. 2006 Aug;387(8):1121-8. IF=2,577
  14. du Bois A, Burges A, Meier W, Pfisterer J, Schmalfeldt B, Richter B, Jackisch C, Staehle A, Kimmig R, Elser G; Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom. Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR). Ann Oncol. 2006 Jan;17(1):93-6. IF=4,319
  15. du Bois A, Schmalfeldt B, Meier W, Sehouli J, Pfisterer J. [Ovarian cancer ? can peritoneal therapy be regarded as new standard?] Zentralbl Gynakol. 2006 Aug;128(4):202-6. German. IF=0,0
  16. du Bois A, Schmalfeldt B, Meier W, Sehouli J, Pfisterer J; Arbeitsgemeinschaft Gynaekologische Onkologie [AGO] Kommission OVAR; AGO Study Group Ovarian Cancer [AGO-OVAR]; Norddeutsche Gesellschaft Fuer Gynaekologische Onkologie [NOGGO]. Ovarian cancer?can intraperitoneal therapy be regarded as new standard in Germany? Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1756-60. Review. IF=1,427
  17. Fasching PA, von Minckwitz G, Fischer T, Kaufmann M, Schultz-Zehden B, Beck H, Lux MP, Jacobs V, Meden H, Kiechle M, Beckmann MW, Paepke S. The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs. Breast Cancer Res Treat. 2007 Jan;101(1):95-104. Epub 2006 Oct 11. IF=4,643
  18. Foekens JA, Atkins D, Zhang Y, Sweep FC, Harbeck N, Paradiso A, Cufer T, Sieuwerts AM, Talantov D, Span PN, Tjan-Heijnen VC, Zito AF, Specht K, Hoefler H, Golouh R, Schittulli F, Schmitt M, Beex LV, Klijn JG, Wang Y. Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol. 2006 Apr 10;24(11):1665-71. IF=11,810
  19. Frank B, Hemminki K, Meindl A, Wappenschmidt B, Klaes R, Schmutzler RK, Untch M, Bugert P, Bartram CR, Burwinkel B. Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk. Int J Cancer. 2006 May 15;118(10):2505-8. IF=4,700
  20. Frank B, Hemminki K, Wappenschmidt B, Klaes R, Meindl A, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B. Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer. Int J Cancer. 2006 Jun 1;118(11):2917-8. No abstract available. IF=4,700
  21. Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis. 2006 Mar;27(3):606-9. Epub 2005 Oct 26. IF=5,108
  22. Gelmon K, Chan A, Harbeck N. The role of capecitabine in first-line treatment for patients with metastatic breast cancer. Oncologist. 2006;11 Suppl 1:42-51. Review. IF=5,134
  23. Golombeck K, Ball RH, Lee H, Farrell JA, Farmer DL, Jacobs VR, Rosen MA, Filly RA, Harrison MR. Maternal morbidity after maternal-fetal surgery. Am J Obstet Gynecol. 2006 Mar;194(3):834-9. IF=3,083
  24. Gross E, Holzl G, Arnold N, Hauenstein E, Jacobsen A, Schulze K, Ramser J, Meindl A, Kiechle M, Oefner PJ. Allelic loss analysis by denaturing high-performance liquid chromatography and electrospray ionization mass spectrometry. Hum Mutat. 2007;28(3):303-311 online Nov. 15 2006  IF=7,923
  25. Harter P, Bois A, Hahmann M, Hasenburg A, Burges A, Loibl S, Gropp M, Huober J, Fink D, Schroder W, Muenstedt K, Schmalfeldt B, Emons G, Pfisterer J, Wollschlaeger K, Meerpohl HG, Breitbach GP, Tanner B, Sehouli J; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Committee; AGO Ovarian Cancer Study Group. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol. 2006 Dec;13(12):1702-10. IF=3,456
  26. Hoenicka M, Lehle K, Jacobs VR, Schmid FX, Birnbaum DE. Properties of the Human Umbilical Vein As a Living Scaffold for a Tissue-Engineered Vessel Graft. Tissue Eng. 2006 Dec 1; [Epub ahead of print] IF=2,887
  27. Holzscheiter L, Biermann JC, Kotzsch M, Prezas P, Farthmann J, Baretton G, Luther T, Tjan-Heijnen VC, Talieri M, Schmitt M, Sweep FC, Span PN, Magdolen V. Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer. Clin Chem. 2006 Jun;52(6):1070-9. Epub 2006 Apr 20. IF=7,717
  28. Hugle B, Astigarraga I, Henter JI, Porwit-Macdonald A, Meindl A, Schuster V. Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease. Eur J Pediatr. 2006 Oct 21; [Epub ahead of print] IF=1,382
  29. Jacobs VR, Morrison JE Jr, Paepke S, Fischer T, Kiechle M. Three-dimensional model for gas flow, resistance, and leakage-dependent nominal pressure maintenance of different laparoscopic insufflators. J Minim Invasive Gynecol. 2006 May-Jun;13(3):225-30. IF=1,278
  30. Jacobs VR, Morrison JE Jr. Application of a locally placed anesthesia catheter for reduction of postoperative pain after mastectomy for breast cancer. Int J Fertil Womens Med. 2006 Sep-Oct;51(5):225-9. IF=0,594
  31. Janni W, Kiechle M, Sommer H, Rack B, Gauger K, Heinrigs M, Steinfeld D, Augustin D, Simon W, Harbeck N, Friese K; ADEBAR Study Group. Study participation improves treatment strategies and individual patient care in participating centers. Anticancer Res. 2006 Sep-Oct;26(5B):3661-7. IF=1,604
  32. Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, Grote V, Diebold J, Jansson V, Schneider K, Belohradsky BH. Classification of Non-Bacterial Osteitis: Retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007 Jan;46(1):154-60. Epub 2006 Jun 17. IF=4,226
  33. Kiechle M. [Genetic testing in patients at risk for carcinoma of the breast] Dtsch Med Wochenschr. 2006 Oct 27;131(43):2420-2. IF=0,653
  34. Krainick-Strobel U, Huber B, Majer I, Bergmann A, Gall C, Gruber I, Hoffmann J, Paepke S, Peisker U, Walz-Mattmuller R, Siegmann K, Wallwiener D, Hahn M. Complete extirpation of benign breast lesions with an ultrasound-guided vacuum biopsy system. Ultrasound Obstet Gynecol. 2006 Dec 14; [Epub ahead of print] IF=2,430
  35. Krol J, Paepke S, Jacobs VR, Paepke D, Euler U, Kiechle M, Harbeck N. G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients. Onkologie. 2006 Apr;29(4):171-8. IF=1,206
  36. Krupka SS, Wiltschi B, Reuning U, Holscher K, Hara M, Sinner EK. In vivo detection of membrane protein expression using surface plasmon enhanced fluorescence spectroscopy (SPFS). Biosens Bioelectron. 2006 Aug 15;22(2):260-7. IF=3,463
  37. Leeners B, Neumaier-Wagner P, Kuse S, Irawan C, Imthurn B, Rath W. Family stability during childhood and the risk to develop hypertensive diseases in pregnancy. Early Hum Dev. 2006 Jul;82(7):441-6. Epub 2006 Jan 27. IF=1,282
  38. Leeners B, Neumaier-Wagner P, Kuse S, Rath W. Smoking and the risk of developing hypertensive diseases in pregnancy: what is the effect on HELLP syndrome? Acta Obstet Gynecol Scand. 2006;85(10):1217-24. IF=1,549
  39. Leeners B, Neumaier-Wagner P, Quarg AF, Rath W. Childhood sexual abuse (CSA) experiences: an underestimated factor in perinatal care. Acta Obstet Gynecol Scand. 2006;85(8):971-6. IF=1,549
  40. Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin Sci (Lond). 2006 Jul;111(1):81-6. IF=2,641
  41. Leeners B, Rath W, Kuse S, Irawan C, Neumaier-Wagner P. The significance of under- or overweight during childhood as a risk factor for hypertensive diseases in pregnancy. Early Hum Dev. 2006 Oct;82(10):663-8. Epub 2006 Mar 29. IF=1,282
  42. Leeners B, Rath W, Kuse S, Neises M, Neumaier-Wagner P. Satisfaction with medical information in women with hypertensive disorders in pregnancy. J Psychosom Res. 2006 Jan;60(1):39-44. IF=2,052
  43. Lehle K, Hoenicka M, Jacobs VR, Schmid FX, Birnbaum DE. Identification and Reduction of Cryoinjury in Endothelial Cells: A First Step toward Establishing a Cell Bank for Vascular Tissue Engineering. Tissue Eng. 2006 Nov 1; [Epub ahead of print] IF=2,887
  44. Lenski C, Frank Kooy R, Reyniers E, Loessner D, Wanders RJ, Winnepenninckx B, Hellebrand H, Engert S, Schwartz CE, Meindl A, Ramser J. The Reduced Expression of the HADH2 Protein Causes X-Linked Mental Retardation, Choreoathetosis, and Abnormal Behavior. Am J Hum Genet. 2007 Feb;80(2):372-7. Epub 2006 Dec 28. IF=12,649
  45. Lossner D, Kessler H, Thumshirn G, Dahmen C, Wiltschi B, Tanaka M, Knoll W, Sinner EK, Reuning U. Binding of small mono- and oligomeric integrin ligands to membrane-embedded integrins monitored by surface plasmon-enhanced fluorescence spectroscopy. Anal Chem. 2006 Jul 1;78(13):4524-33. IF=5,635
  46. Lubs H, Abidi FE, Echeverri R, Holloway L, Meindl A, Stevenson RE, Schwartz CE. Golabi-Ito-Hall syndrome results from a missense mutation in the WW domain of the PQBP1 gene. J Med Genet. 2006 Jun;43(6):e30. IF=4,330
  47. Magdolen U, Auernheimer J, Dahmen C, Schauwecker J, Gollwitzer H, Tubel J, Gradinger R, Kessler H, Schmitt M, Diehl P. Growth promoting in vitro effect of synthetic cyclic RGD-peptides on human osteoblast-like cells attached to cancellous bone. Int J Mol Med. 2006 Jun;17(6):1017-21. IF=2,090
  48. Martinez-Garay I, Tomas M, Oltra S, Ramser J, Molto MD, Prieto F, Meindl A, Kutsche K, Martinez F. A two base pair deletion in the PQBP1 gene is associated with microphthalmia, microcephaly, and mental retardation. Eur J Hum Genet. 2007 Jan;15(1):29-34. Epub 2006 Oct 11. IF=3,251
  49. Maurer T, Schnelzer A, Kremer M, May F, Hartung R. [Abdominal colic caused by mature cystic teratoma of the ovary.] Urologe A. 2006 Oct 27; [Epub ahead of print] German. IF=0,471
  50. Meyer TP, Hofmann B, Zaisserer J, Jacobs VR, Fuchs B, Rapp S, Weinauer F, Burkhart J. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. Cytotherapy. 2006;8(3):265-76. IF=1,795
  51. Miehe U, Kadyrov M, Neumaier-Wagner P, Bartz C, Rath W, Huppertz B. Expression of the actin stress fiber-associated protein CLP36 in the human placenta. Histochem Cell Biol. 2006 Oct;126(4):465-71. Epub 2006 Apr 12. IF=2,239
  52. Morrison JE Jr, Jacobs VR. Classic intrafascial supracervical hysterectomy (CISH): 10-year experience. JSLS. 2006 Jan-Mar;10(1):26-9. IF=0,0
  53. Mueller D, Link TM, Monetti R, Bauer J, Boehm H, Seifert-Klauss V, Rummeny EJ, Morfill GE, Raeth C. The 3D-based scaling index algorithm: a new structure measure to analyze trabecular bone architecture in high-resolution MR images in vivo. Osteoporos Int. 2006 Oct;17(10):1483-93. IF=4,216
  54. Ohlinger R, Heyer H, Thomas A, Paepke S, Warm H, Klug U, Frese H, Schulz K, Schimming A, Schwesinger G, Kohler G, Wodny M, Kohlmann T, Grunwald S. Non-palpable breast lesions in asymptomatic women: diagnostic value of initial ultrasonography and comparison with mammography. Anticancer Res. 2006 Sep-Oct;26(5B):3943-55. IF=1,604
  55. Paepke S, Jacobs VR, Paepke D, Euler U, Blohmer JU, Warm M, Ohlinger R, Fischer T, Kiechle M, Harbeck N. Critical appraisal of primary systemic endocrine therapy in receptor-positive postmenopausal breast cancer: an update. Onkologie. 2006 May;29(5):210-7. IF=1,206
  56. Prezas P, Arlt MJ, Viktorov P, Soosaipillai A, Holzscheiter L, Schmitt M, Talieri M, Diamandis EP, Kruger A, Magdolen V. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem. 2006 Jun;387(6):807-11. IF= 2,577
  57. Prezas P, Scorilas A, Yfanti C, Viktorov P, Agnanti N, Diamandis E, Talieri M. The role of human tissue kallikreins 7 and 8 in intracranial malignancies.
    Biol Chem. 2006 Dec;387(12):1607-12. IF=2,577
  58. Prior JC, Tremollieres F, Forsmo S, Seifert-Klauss V. Unsuccessful attempt to demonstrate progesterone?s bone formation actions. Am J Obstet Gynecol. 2006 May;194(5):1502-3; author reply 1503-4. IF=3,083
  59. Rattenhuber J, Schmalfeldt B, Fischer T, Schneider KT. [Acute ovarian vein thrombosis in the third trimestre] Zentralbl Gynakol. 2006 Dec;128(6):366-8. IF=0,0
  60. Reuning U, Schmitt M, Luber B, Beck V, Magdolen V. Methods to analyze the effects of the urokinase system on cancer cell adhesion, proliferation, migration, and signal transduction events. Methods Mol Med. 2006;120:427-40. IF=0,0
  61. Schauwecker J, Wirthmann L, Schmitt M, Tuebel J, Magdolen U, Gradinger R, Mittelmeier W, Diehl P. Effect of extracorporeal high hydrostatic pressure on cellular outgrowth from tumor-afflicted bone. Anticancer Res. 2006 Jan-Feb;26(1A):85-9. IF=1,604
  62. Schmalfeldt B, du Bois A, Burges A, Emons G, Fink D, Gropp M, Hasenburg A, Jager W, Kimmig R, Kiechle M, Kommoss F, Kreienberg R, Kuhn W, Luck HJ, Meier W, Munstedt K, Ortmann O, Pfisterer J, Richter B, Runnebaum I, Schroder W, Sehouli J, Tanner B, Wagner U, Weis J. [Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO] Zentralbl Gynakol. 2006 Feb;128(1):11-7. German. IF=0,0
  63. Schmitt M, Sturmheit AS, Welk A, Schnelldorfer C, Harbeck N. Procedures for the quantitative protein determination of urokinase and its inhibitor, PAI-1, in human breast cancer tissue extracts by ELISA. Methods Mol Med. 2006;120:245-65. IF=0,0
  64. Schneider KT, Butterwegge M, Daumer M, Dudenhausen J, Feige A, Gonser M, Hecher K, Jensen A, Koepcke E, Kunzel W, Roemer VM, Schmidt S, Vetter K. [Use of CTG during pregnancy and childbirth] Z Geburtshilfe Neonatol. 2006 Apr;210(2):38-49. IF=0,0
  65. Schneider KT. [Are so man cesarean sections necessary? (interview by Dr. Thomas Meissner)] MMW Fortschr Med. 2006 May 18;148(20):17. IF=0,0
  66. Schneider KT. [Comments on the Guideline: Use of CTG during pregnancy and childbirth] Z Geburtshilfe Neonatol. 2006 Apr;210(2):36-7. IF=0,0
  67. Schneider KT. [Guidelines for obstetrics and neonatology.] Z Geburtshilfe Neonatol. 2006 Apr;210(2):35. IF=0,0
  68. Sehouli J, Oskay-Ozcelik G, Kuhne J, Stengel D, Hindenburg HJ, Klare P, Heinrich G, Schmalfeldt B, Mertens H, Camara O, Lichtenegger W; Ovarian Cancer Study Group of the Nord-Ostdeutsche Gesellschaft fur Gynakologische Onkologie (NOGGO). Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial. Ann Oncol. 2006 Jun;17(6):957-61. IF=4,319
  69. Seifert-Klauss V, Link T, Heumann C, Luppa P, Haseitl M, Laakmann J, Rattenhuber J, Kiechle M. Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study. Maturitas. 2006 Nov 20;55(4):317-24. IF=2,004
  70. Seitz S, Korsching E, Weimer J, Jacobsen A, Arnold N, Meindl A, Arnold W, Gustavus D, Klebig C, Petersen I, Scherneck S. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression. Genes Chromosomes Cancer. 2006 Jun;45(6):612-27. IF=3,937 
  71. Stemmler HJ, Schmitt M, Harbeck N, Willems A, Bernhard H, Lassig D, Schoenberg S, Heinemann V. Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. Oncol Rep. 2006 May;15(5):1373-7. IF=1,572
  72. Tchatchou S, Wirtenberger M, Hemminki K, Sutter C, Meindl A, Wappenschmidt B, Kiechle M, Bugert P, Schmutzler RK, Bartram CR, Burwinkel B. Aurora kinases A and B and familial breast cancer risk. Cancer Lett. 2006 Jun 6; [Epub ahead of print] IF=3,049
  73. Thussbas C, Nahrig J, Streit S, Bange J, Kriner M, Kates R, Ulm K, Kiechle M, Hoefler H, Ullrich A, Harbeck N. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. J Clin Oncol. 2006 Aug 10;24(23):3747-55. IF=11,810
  74. Vaclavicek A, Hemminki K, Bartram CR, Wagner K, Wappenschmidt B, Meindl A, Schmutzler RK, Klaes R, Untch M, Burwinkel B, Forsti A. Association of prolactin and its receptor gene regions with familial breast cancer. J Clin Endocrinol Metab. 2006 Apr;91(4):1513-9. Epub 2006 Jan 24. IF=6,020
  75. Varga D, Hoegel J, Maier C, Jainta S, Hoehne M, Patino-Garcia B, Michel I, Schwarz-Boeger U, Kiechle M, Kreienberg R, Vogel W. On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. Mutagenesis. 2006 Sep;21(5):313-20. IF=2,094
  76. Viehweg P, Bernerth T, Heinig A, Kiechle M, Buchmann J, Koelbl H, Laniado M, Helen Heywang-Kobrunner S. MR-guided intervention in women at high hereditary risk of breast cancer due to both family and personal history of breast cancer. Breast J. 2006 Nov-Dec;12(6):549-58. IF=0,0
  77. Viehweg P, Bernerth T, Kiechle M, Buchmann J, Heinig A, Koelbl H, Laniado M, Heywang-Kobrunner SH. MR-guided intervention in women with a family history of breast cancer. Eur J Radiol. 2006 Jan;57(1):81-9. Epub 2005 Dec 20. IF=1,888
  78. Wagner U, du Bois A, Pfisterer J, Huober J, Loibl S, Luck HJ, Sehouli J, Gropp M, Stahle A, Schmalfeldt B, Meier W, Jackisch C. Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy-A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6). Gynecol Oncol. 2006 Dec 8; [Epub ahead of print] IF=2,251
  79. Wilkening S, Bermejo JL, Burwinkel B, Klaes R, Bartram CR, Meindl A, Bugert P, Schmutzler RK, Wappenschmidt B, Untch M, Hemminki K, Forsti A. The single  nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer. Cancer Res. 2006 Jan 15;66(2):646-8. IF=7,616
  80. Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis. 2006 Aug;27(8):1655-60. Epub 2006 Feb 25. IF=5,108
  81. Wirtenberger M, Schmutzhard J, Hemminki K, Meindl A, Sutter C, Schmutzler RK, Wappenschmidt B, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B. The functional genetic variant Ile646Val located in the kinase binding domain of the A kinase anchoring protein 10 is associated with familial breast cancer. Carcinogenesis. 2006 Sep 6; [Epub ahead of print]  IF=5,108
  82. Wirtenberger M, Tchatchou S, Hemminki K, Klaes R, Schmutzler RK, Bermejo JL, Chen B, Wappenschmidt B, Meindl A, Bartram CR, Burwinkel B. Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer. Carcinogenesis. 2006 Mar;27(3):593-8. Epub 2005 Oct 18. IF=5,108
  83. Wirtenberger M, Tchatchou S, Hemminki K, Schmutzhard J, Sutter C, Schmutzler RK, Meindl A, Wappenschmidt B, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis. 2006 Nov;27(11):2201-8. Epub 2006 May 15. IF=5,108

 

Summe der Impaktfaktoren in 2006: 303,908 IF-Punkte